Surgery – Radioactive substance applied to body for therapy – Radioactive substance placed within body
Patent
1992-03-19
1993-05-25
Rosenbaum, C. Fred
Surgery
Radioactive substance applied to body for therapy
Radioactive substance placed within body
600 3, 128657, A61M 3612
Patent
active
052135616
ABSTRACT:
The incidence of restenosis after angioplasty is reduced by exposing the potentially stenotic site to radiation from a source within the same vascular structure in which the site is located. The radioactive source can be mounted at the distal end of a guidewire, or in a balloon catheter, or on a balloon expansible stent, and is inserted through the vascular structure to the site to be exposed.
REFERENCES:
patent: 3674006 (1972-07-01), Holmer
patent: 3866050 (1975-02-01), Whitfield
patent: 4819618 (1989-04-01), Liprie
patent: 4851694 (1989-07-01), Rague et al.
patent: 4963128 (1990-10-01), Daniel et al.
patent: 4976680 (1990-12-01), Hayman et al.
patent: 5059166 (1991-10-01), Fischell et al.
Advanced Cardiovascular Systems, Inc. brochure "Hartzler ACX.TM. Coronary Dilatation Catheter".
Scimed.TM., GSSC 0.018 Skinny.TM. PTCA Dilatation Catheter Instructions for use.
Martin H. Frank
Weinstein Joseph S.
Lewis Wm.
Rosenbaum C. Fred
LandOfFree
Method and devices for preventing restenosis after angioplasty does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and devices for preventing restenosis after angioplasty, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and devices for preventing restenosis after angioplasty will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-894351